DigiBiomics
PulmoDeep
Screening and diagnosis of lung infections and related diseases anomalies for early outbreak detection.
DigiBiomics is a pioneering Healthcare AI company, offering PulmoDeep, a cutting-edge tool for screening and early detection of lung diseases. Focused on predicting Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis through deep learning, PulmoDeep can be licensed to health authorities for visa screenings and proactive disease detection.
94%
Accuracy
94%
Long-term efficiency
83%
Cost-effective
Our Newsletter.
Get instant news by subscribe to our daily newsletter
Copyright @2024 DigiBiomic
OR